Best CT (computer tomography) doctors: TOP 541 doctors

Dr. Arye Blachar is a diagnostic radiologist with expertise in abdominal imaging, hepatic perfusion imaging, CT colonography, and body MR imaging. He focuses on imaging studies of the abdominal and pelvic organs. He has a special interest in diagnosing cancers of the liver, lung, prostate, stomach, adrenal glands, breast, and esophagus, as well as peritoneal mesothelioma.

Dr. Blachar has been recognized as one of the best teachers at Tel Aviv University Sackler School of Medicine. Forbes Israel named him one of the country's top physicians in 2021. His honors include a Certificate of Merit for research, Magna Cum Laude for his work on portal vein thrombosis, and an Editors’ Recognition Award from the European Radiology Journal.

Education and Expertise

Istanbul University Istanbul Faculty of Medicine - 2010

İstanbul Metin Sabancı Baltalimanı Bone Diseases Training and Research Hospital – Orthopedics and Traumatology – 2016

Work experiences

Private Family Hospital

Private Atakoy Hospital

Sancaktepe Health Center

Baltalimanı Bone Diseases Training and Research Hospital

Diyarbakir Selahaddin Eyyubi State Hospital

Subjects He Is Competent And Interested In:

Knee Calcification

Knee pain

Meniscus Tear

Knee Ligament Injuries

Carpal Tunnel Syndrome

Neck pain

Orthopedic Diseases

Shoulder Instability

Shoulder Dislocation

Shoulder pain

Meniscus

Recurrent Shoulder Dislocations

Hip and Knee Prosthesis

Thesis:

1. Mentese ST, Colak O, Gunenc YE, Tufekci K, Eren OC, Bozkurt SU. The Effect of Hyperelastic Bone Produced with Three Dimensional Bioprinter in Heterotopic Bone Formation.

Peer Reviewed Abstracts

1. Kuru P, Bilgin S, Mentese ST, Tazegul G, Ozgur S, Cilingir OT, Akakin D, Yarat A, Kasimay O. Ameliorative Effect of Chronic Moderate Exercise in Smoke Exposed or Nicotine Applied Rats From Acute Stress Nicotine Tob Res. 2014 Sep 19. pii: ntu182. (As Senior Medical Student)

2. Özdemir ZN, Tazegül G, Kuru P, Bilgin S, Menteşe ST, Erzik C, Şirvancı S, Yeğen B. Nicotine alleviates colitis-induced damage in rats via its anti-oxidative activity. Marmara Medical Journal 2014; 27: 13-20 DOI: 10.5472/MMJ.2013.03125.1 (As Senior Medical Student)

3. Özay Özkaya Mutlu, Mert Canlı, Semih Tiber Menteşe, Ahmet Dilber; Retrospective Comperative Analysis of Preoperative Lymph Node Imaging and Pathological Results in Malignant Melanoma Patients, October Antalya 2017

Peer Reviewed Posters

1. Özlem Çolak, Semih Tiber Menteşe, Özay Özkaya, Deniz Özcan; Case Report: Differentiation of Intraoral lesions, Squamous Cell Carcinoma or Pseudoepitheliamatous Hyperplasia, October 2016, Antalya, Turkey.

2. Özay Özkaya, Semih Tiber Menteşe, Özlem Çolak, İlker Üsçetin; The Effect of Staging on Survey in Malignant Melanoma, October 2016, Antalya, Turkey.

3. Özay Özkaya Mutlu, Semih Tiber Menteşe, Ahmet Dilber, Özlem Çolak; Case Report: Free Adductor Magnus Flap Reconstruction of Calcanel Defect, October 2017, Antalya, Turkey.

4. Özlem Çolak, Özay Özkaya Mutlu, Kadri Özer, S. Tiber Menteşe; Multifunctional Use of Elongated Temporoparietal Fascia Flap in Periorbital Reconstruction, October 2018, Antalya, Turkey.

5. Ayberk Akçay, Özlem Çolak, Semih Tiber Menteşe; Case Report: Superior Epigastric Artery Perforator Propellar Flap Reconstruction of Anterior Chest Wall Defect, October 2018, Antalya, Turkey.

6. Batıbey Batmacı, Harun Erbek, Semih Tiber Menteşe, Türkay Gökeri, İlker Üsçetin, Ayşin Karasoy Yeşilada; Malign Hand Tumors in the Last Five Years In Our Clinic, September 2019, Samsun, Turkey.

7. Semih Tiber Menteşe, Harun Erbek, Özlem İmren, Mert Canlı, İlker Üsçetin, Ayşin Karasoy Yeşilada; Regional Fasciectomy Treatment Results of Dupuytren’s Contracture Patients, September 2019, Samsun, Turkey.

8. Semih Tiber Menteşe, Harun Erbek, Türkay Gökeri, Özlem İmren, Mert Canlı, Ayşin Karasoy Yeşilada; The Comparison of Results of Late Term Primarily Fixed and Hunter Prosthesis Used Flexor Digitorum Profundus Injuries, September 2019, Samsun, Turkey.

9. Semih Tiber Menteşe, Özlem Çolak, Mert Canlı, İlker Üsçetin, Ayşin Karasoy Yeşilada; Extensor Indicis Proprius Transfer Supplied with Ruptured Extensor Pollicis Longus (EPL) Proximal Portion in a Patient with Recurrent EPL Rupture, September 2019, Samsun, Turkey.

10. Özlem Çolak, Mahir Gökbulut, Selman Taşkın, Tuğçe Yasak Par, Semih Tiber Menteşe, İlker Üsçetin; Lesions Prediagnosed as Vascular Tumors; September 2020, İstanbul, Turkey.

11. Özlem Çolak, Tuğçe Yasak Par, Emre Gunenc, Selman Taşkın, Semih Tiber Menteşe, İlker Üsçetin; Flap Reconstruction of Periorbital Area Zone 2 Tumor Excision Defects, September 2020, İstanbul, Turkey.

12. Özlem Çolak, Emre Gunenc, Selman Taşkın, Tuğçe Yasak Par, Semih Tiber Menteşe, İlker Üsçetin; Thoracal Wall Reconstruction in a Male Patient with Poland Syndrome, September 2020, İstanbul, Turkey.

13. Özlem Çolak, Burak Yılmaz, Semih Tiber Menteşe, Tuğçe Yasak, İlker Üsçetin; A Rare Skin Malignancy: Sebaceous Carcinoma, November 2021, Antalya, Turkey.

Oral Presentation:

1. The Effect of Apelin on Indomethacin Induced Gastric Ulcer, World Gastroenterology Subregional Meeting, November 2011, Antalya, Turkey. (As Senior Medical Student)

2. Özlem Çolak, Semih Tiber Menteşe, Özay Özkaya Mutlu, İlker Üsçetin; Case Report: 4 Different Merkel Cell Carcinoma, October 2018, Antalya, Turkey.

3. Özlem Çolak, Semih Tiber Menteşe, İlker Üsçetin, Özay Özkaya Mutlu; Our Clinical Experience, Retrospective Analysis of Gynecomastia Patients, October 2018, Antalya, Turkey.

4. Semih Tiber Menteşe, Akif Ayberk Akçay, İlker Üsçetin, Harun Erbek, Ayşin Karasoy Yeşilada; Our Approach to Congenital Hand Anomalies Between 2015-2019 Time Periods in Our Clinic, April 2019, İstanbul, Turkey.

5. Semih Tiber Menteşe, Mert Canlı, Özlem Çolak, Batıbey Batmacı, Ayşin Karasoy Yeşilada; Results of Repair Through Nerve Graft in Our Clinic in 2015-2019 Time Periods, April 2019, İstanbul, Turkey.

6. Semih Tiber Menteşe, Mert Canlı, Özlem Çolak, Harun Erbek, Ayşin Karasoy Yeşilada; The Evaluation of Long Term Results of Mallet Finger Cases Operated 2015-2019 Periods in Our Clinic, April 2019, İstanbul, Turkey.

7. Akif Ayberk Akçay, Semih Tiber Menteşe, Ayşin Karasoy Yeşilada, Özlem Çolak; The Evulation of Biomechanical and Histologic Aspects the Effect of Direct Thrombin inhibitors on Tendon Healing, September 2019, Samsun, Turkey.

8. Özlem Çolak, Harun Erbek, Tuğçe Yasak Par, Selman Taşkın, Mert Canlı, Semih Tiber Menteşe, İlker Üsçetin; Comparison of Fat Pad Transposition and Fat Graft Application After Fat Pad Resection in Transconjunctival Lower Eyelid Blepharoplasty, September 2020, İstanbul, Turkey

9. Özlem Çolak, Zeynep Öykü Gürel, Semih Tiber Menteşe, İlker Üsçetin, Mahir Gökbulut; Versatile Use of Thoracodorsal Artery Perforator Flap in Axillary Reconstruction, November 2021, Antalya, Turkey.

10. Türkay Gökeri, Tiber Menteşe, Özlem Çolak, Günay Güldoğuş, Tuğçe Yasak Par; Effects of Covid-19 Pandemics on Emergency Plastic Surgery Patiens Admission, November 2021, Antalya, Turkey.

11. Özlem Çolak, Tuğçe Yasak Par, Semih Tiber Menteşe, Zeynep Öykü Gürel, İlker Üsçetin, Mahir Gökbulut ; Retrospective Analysis of Fourniere’s Gangrene Reconstruction Patients Operated From 2010 to 2021, November 2021, Antalya, Turkey.

12. Özlem Çolak, Semih Tiber Menteşe, Günay Güldoğuş, Tuğçe Yasak Par; Foot Defect Reconstruction with a Superficial Circumflex İliac Artery Flap Including a Bony Component, November 2021, Antalya, Turkey.

13. Özlem Çolak, Semih Tiber Menteşe, Günay Güldoğuş, Ayça Ergan Şahin; Reconstruction of Wrist Dorsum with a Very Thin Flap: Superficial Circumflex İliac Artery Perforator Flap, November 2021, Antalya, Turkey.

14. Semih Tiber Menteşe, Özlem Çolak, Caner Ali İlhan, Tuğçe Yasak Par, İlker Üsçetin; An Effective Solution for Wide Abdominal Wall Defect: Free Latissimus Dorsi Flap, November 2021, Antalya, Turkey.

15. Özlem Çolak, Semih Tiber Menteşe, Caner Ali İlhan, Ayça Ergan Şahin; An Early and Higher Function Providing Reconstruction Option in Phalangeal Bony Defects, November 2021, Antalya, Turkey.

Experiences:

1. Cardiovascular Surgery Clinic, Cardiology Hospital C. I. Parhon Iaşi/ROMANIA 2010 (IFMSA Medical Student Exchange Program)

2. Gastroenterology Clinic, Hospital Clínico Universitario Lozano Blesa Zaragoza/SPAIN 2011 (IFMSA Medical Student Exchange Program)

3. Obstetrics and Gynecology Clinic, Plastic and Reconstructive Surgery Clinic, General Surgery Clinic, Sapienza University of Rome, Rome/ITALY 2012 (ERASMUS Student Exchange Program)

4. Cardiology Clinic, Herlev Hospital, Copenhagen/DENMARK 2012 (IFMSA Medical Student Exchange Program)

5. General Surgery Clinic, Hippokration General Hospital, Athens/GREECE 2012 (Observership As Medical Student)

Courses:

1. National XXXI. Basic Microsurgery Course, June 2018, Marmara University Medical Faculty, İstanbul.

2. XXVIII. Laboratory Animal Science for Researchers Course, September 2019, YUDETAM, Yeditepe University Experimental Research Center

Professor Drach is a specialist in oncology with a PhD from the Medical University of Vienna. He has experience in research, internal medicine, hematologic oncology, nutrition, and lifestyle in cancer. He is the Director of the Josefstadt Private Clinic in Vienna and a member of the Board of Directors of the Austrian Society of Hematology and Oncology. He has published more than 120 scientific papers and given more than 200 lectures/presentations.

Dr. Viola Fox is the Chief Physician at the Clinic for Haematology, Oncology, and Palliative Medicine at BKZ Solingen. This clinic is a certified interdisciplinary cancer center. Dr. Fox is a leading expert in drug therapy for tumor diseases in Germany and Europe. She has more than 15 years of experience in this field.

She is a member of the German Society of Oncology and Haemato-oncology (GDHO), the German Association of Physicians, and the American Association for Cancer Research. Dr. Fox is also active in molecular biology research. Her work supports progress in cancer treatment and molecular diagnostics.

Her main areas of expertise are chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Dr. Fox is known for her innovative methods and strong commitment to patient care. Her efforts have led to high recovery rates and recognition from her peers.

Specializations

Brain Tumors

Aneurysm Surgery

Pituitary Surgery

Spine Surgery

Waist neck and back hernias

Spine Tumors

Spinal Fractures

Peripheral Nerve Surgery

Dr. Victor Alexander Krol - Chief of Gastroenterology, Internal Medicine and Obesity Treatment Center at Martinus Hospital

Dr. Victor Alexander Krol is a highly qualified specialist, heading the departments of gastroenterology and internal medicine. With many years of experience and deep knowledge in his field, Dr. Krol has established himself as an outstanding expert, providing patients with comprehensive treatment and an individual approach. He actively uses the latest methods of diagnosis and treatment of diseases of the gastrointestinal tract, metabolism, as well as diseases of the cardiovascular and respiratory systems.

Dr. Krol is also the director of the certified Obesity Treatment Center at Martinus Hospital, which provides surgical and endoscopic treatments for obesity. The center uses advanced technology to diagnose and treat obesity (adiposis), including methods such as bariatric surgery, endoscopic weight loss, and specialized programs for patients with different stages of obesity. The center is certified to high standards and has excellent results in the treatment of this serious disease.

The Gastroenterology Department, headed by Dr. Krol, diagnoses and treats diseases of the stomach, intestines, liver, pancreas, and gallbladder. The doctors of the department use a wide range of methods, including endoscopic procedures, ultrasound, and other modern diagnostic technologies.

The Department of Internal Medicine covers a wide range of diseases, including cardiology, diabetology, infectology, and therapy of respiratory and renal diseases. Dr. Krol and his team provide a comprehensive approach to treatment using the most advanced methods of medicine.

Thanks to his high professionalism and humane approach to each patient, Dr. Krol deservedly enjoys the respect of colleagues and patients.

Key Areas of Expertise:

Trauma and Emergency Orthopedics: Dr. Aydın is an expert in managing traumatic injuries, including fractures, dislocations, and soft tissue injuries. His approach is focused on minimizing recovery time and ensuring the best possible functional outcomes for patients.

Joint Replacement Surgery: Specializing in hip, knee, and shoulder replacement surgeries, he has performed numerous successful joint replacements, offering patients relief from chronic pain and enhanced mobility.

Sports Injuries: Dr. Aydın has an in-depth understanding of sports-related injuries, including ligament tears, tendon ruptures, and cartilage damage. He employs both conservative and surgical techniques to help athletes recover and return to their active lifestyles.

Spine Surgery: His experience extends to treating various spine conditions, such as degenerative diseases, herniated discs, and spinal deformities. He uses minimally invasive techniques whenever possible to reduce recovery times and improve surgical outcomes.

Pediatric Orthopedics: Dr. Aydın also has expertise in treating musculoskeletal conditions in children, such as congenital deformities, growth plate injuries, and scoliosis.

Arthroscopy: Skilled in minimally invasive arthroscopic surgery, Dr. Aydın can diagnose and treat conditions affecting joints, including the knee, shoulder, and ankle, with reduced scarring and quicker recovery.

Complex Trauma and Reconstruction: With a focus on treating complex fractures and trauma cases, he is skilled in using advanced surgical techniques to restore function and structure to severely injured bones and soft tissues.

Academic and Research Contributions:

Dr. Aydın’s position as an Associate Professor underscores his dedication to advancing the field through both teaching and research. He actively contributes to medical literature, presenting innovative findings and new treatment methodologies in orthopedics and traumatology. His research interests include improving patient outcomes in fracture healing, developing better surgical techniques, and exploring the use of regenerative medicine in orthopedic care.

Clinical Approach:

Dr. Aydın takes a patient-centered approach, tailoring treatment plans to meet the unique needs of each individual. He emphasizes early intervention, advanced diagnostic tools, and personalized rehabilitation strategies to ensure optimal recovery.

Through his extensive knowledge and experience in orthopedics and traumatology, Dr. Murat Aydın has earned a reputation for excellence in patient care, making him a highly respected figure in his field.

Professional experience

Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.

Membership in scientific societies

National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)

President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).

Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).

Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).

Research and Teaching

Principal investigator of 100 national and international clinical trials.

7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).

10 projects from private foundations, received on a competitive basis (7 as principal investigator).

He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).

His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.

Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.

Education :

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Education and Specialization

• Uludağ University Faculty of Medicine
• Selçuk University Meram Faculty of Medicine, Department of Cardiology – Specialization

Experience

• Cleveland Clinic, Invasive Cardiology Unit, Ohio, USA
• Akdeniz University Faculty of Medicine, Department of Cardiology
• Antalya Yaşam Hospitals  

Education and Specialization

• 1982 - 1987: Ege University Faculty of Medicine
• 1987 - 1993: İzmir Atatürk Training and Research Hospital – Specialization

Experience

• 1993 - 1996: İzmir Atatürk State Hospital – Specialist Doctor
• 1996 - 1998: İnönü University Faculty of Medicine – Assistant Professor
• 1998 - 2001: İnönü University Faculty of Medicine – Associate Professor
• 2001 - 2005: Başkent University Adana Practice and Research Hospital – Associate Professor
• 2006 - 2007: Başkent University Adana Practice and Research Hospital – Professor
• 2007 - 2013: Başkent University Istanbul Practice and Research Hospital – Professor
• 2013 - 2015: Hisar Intercontinental Hospital, Istanbul – Professor
• 2015 - Present: Acıbadem Bakırköy Hospital, Istanbul – Professor

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Dr. Séverine Iborra is the Chief Physician of the Department of Gynecology and Obstetrics at Städtisches Klinikum Solingen. Her responsibilities include obstetrics, the delivery room, the neonatal unit, and gynecology. The department also includes the Senology/Breast Clinic at the Bergisches Breast Center Solingen, led by Dr. Manuela Seifert.

Dr. Séverine Iborra is originally from France. She began her medical studies at the University of Lyon and later transferred to Albert-Ludwigs University in Freiburg, where she received her medical license in 2007. She earned her doctorate in 2008 for experimental research in molecular oncology. From August 2008 to November 2013, Dr. Iborra worked as a resident at the University Women’s Clinic in Freiburg. After passing her specialist exams in gynecology and obstetrics, she continued her career as a specialist at the same clinic. In November 2015, she moved to RWTH University Hospital Aachen as a senior physician.

At the Clinic for Gynecology and Obstetrics, under the leadership of Prof. Dr. E. Stickeler, Dr. Iborra led the obstetrics department from 2017 to 2019. Since December 2017, she was responsible for organizing education in the department, and in October 2019, she became the Managing Senior Physician and Personnel Senior Physician of the clinic, a position she held until she moved to Solingen.

In addition to her scientific work, with numerous publications and presentations at major gynecological conferences, Dr. Iborra deepened her medical specialties. She obtained certifications in oncological diagnostics and therapy from the Gynecological Oncology Working Group, as well as additional qualifications in Cervical Pathology and Colposcopy (AGCPC), Urogynecology and Pelvic Reconstructive Surgery (AGUP), and the Professional Association of Gynecologists (BVF).

In 2019, Dr. Iborra successfully completed further specialization in “Gynecological Oncology” and “Special Obstetrics and Perinatal Medicine.” She is an active member of leading German medical societies in her field, including the German Society for Gynecology and Obstetrics, the Cervical Pathology and Colposcopy Working Group, and the German Society for Prenatal and Birth Medicine.

Treatments Offered in Our Gynecology Department

• Hysteroscopy and Dilation and Curettage (D&C) for diagnostic and therapeutic purposes.
• Removal of abnormal or symptomatic ovarian findings, such as cysts, while preserving the remaining ovary.
• Oophorectomy (removal of ovaries) in cases of abnormalities or preventively when indicated.
• Myomectomy (removal of uterine fibroids) while preserving the uterus.
• Conservative treatment of fibroids: either medication or embolization performed by radiology specialists.
• Hysterectomy with or without removal of the cervix.
• Diagnosis and clarification of unclear findings in the cervix, vagina, and vulva.
• Dysplasia treatment.
• Endometriosis management.
• Cancer treatment for vulvar, vaginal, cervical, uterine, and ovarian cancers.
• Treatment for incontinence and/or pelvic organ prolapse.

Whenever possible, we offer all procedures as minimally invasive treatments using laparoscopy or the Da Vinci robotic system.

Birth Date: 22-11-1973

Place of Birth: Hatay-Turkey

Medical Faculty: Marmara University Medical Faculty(1990-1997 )

Cardiology fellowship:Istanbul University Institution of Cardiology:(1998-2003)

Associate Proffesor of cardiology: 2002

Proffessor of Cardiology:2017

Previous Positions

Istanbul University Institution of Cardiology:Fellow of cardiology 1998-2003

Cardiologist : Kastamonu Şerife Bacı State Hospital 2004-2007

Cardiologist: Istanbul Bağcılar Training and Research Hospital 2007- 2012

Associate Proffesor of cardiology: Istanbul Bağcılar Training and Research Hospital 2012-2013

Head of Cardiology Department: University of Health Sciences ,Istanbul Bağcılar Training and Research Hospital 2013-2024

Current Position

Dırector of   Cardiology departemant : Medipol University Acıbadem District  Hospital 2024--

Memberships :

 Turkish Society of Cardiology,(Vice president and president of Scientific comitee), European Society of Cardiology, European Atherosclerosis Society, American Heart Association, American Society of Hypertension, Former president of Turcic world Cardiology Association, 

Academic Interests:

Interventional Cardiology, Structural Heart Disease, Heart failure,

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Experience

On his return from London, he organized and directed the Arrhythmia Unit of the Cardiology Service of the University Hospital Nuestra Señora del Pino in Las Palmas until 2000.

He later became Deputy Director of the Arrhythmia Department and Director of the Electrophysiology Laboratory at the Jimenez Diaz Foundation in Madrid.

Professor of Cardiology at the Autonomous University and Director of the North American Society of Pacing and Electrophysiology (Heart Rhythm Society) Fellowship Program, positions he held for 6 years before moving to the Quironsalud University Hospital of Madrid in 2006.

Dr. Cabrera has been head of the cardiology department at the Quironsalud University Hospital of Madrid since its opening in 2006.

Since January 2013, he has also been Head of the Cardiology Department at the Ruber Juan Bravo Hospital Complex and, in 2022, Head of Service at the new Olimpia Center.

He is a professor at the European University of Madrid, where he heads the Department of Clinical and Fundamental Translational Cardiology.

Qualification

Doctorate in Medicine and Surgery from the Faculty of Medicine of the University of Granada. From 1994 to 1996 he completed postgraduate training as an interventional cardiologist in the Arrhythmia Unit (Cardiac Electrophysiology Laboratory) of the Jiménez Díaz Foundation in Madrid.

Senior Research Fellow. National Heart and Lung Institute. Royal Brompton. Paediatric Heart Morphology under the direction of Prof. Robert H. Anderson in London (UK) in 1997.

Research and Teaching

Member of the Spanish Society of Cardiology, SEC Arrhythmia Section, European Society of Cardiology, Arrhythmia Working Group, European Heart Rhythm Association, North American Society of Pacing and Electrophysiology.

He serves on numerous committees for the selection and monitoring of fellowships and research projects of various national and international cardiology and cardiac arrhythmia societies.

Reviewer of articles for publication in the most relevant journals in the specialty. Journal of the Spanish Society of Cardiology, Heart Rhythm, Journal of Cardiovascular Electrophysiology, PACE, Europace, Heart Circulation, Journal of the American College of Cardiology, Electrophysiology of Circulation, Journal of Interventional Cardiovascular Electrophysiology.

Member of the European Society of Cardiology

Member of the Arrhythmia Working Group

European Society of Cardiology

Member of the Arrhythmia Section of the Spanish Society of Cardiology.

Member of the European Society of Cardiology (FESC)

Member of the European Heart Rhythm Association.

Member of the Selection and Control Committee of the Spanish Society of Cardiology. Post-Residency Research Training Fellowships 2001-2002/2002-2003.

Evaluator and member of the selection committee for research, technological development and innovation projects of the Government of Extremadura. Ministry of Education, Science and Technology (2001-2004).

Member of the Spanish research group. Integrated Action Programme between Spain and the United Kingdom. Directorate General of Higher Education and Research (reference HB 1998-0030). Project title: Anatomical study of the cavities of the human heart and its application to clinical electrophysiology.

Member of the Spanish research group. Integrated Action Programme between Spain and Austria. Directorate General for Higher Education and Research (reference HU 1999-0002). Project title: Electromorphological analysis of the terminal crest and posterior pectineus muscle. Its importance as a morphological substrate in different types of supraventricular tachycardias.

Participation in the clinical commission and protocol of the study AZIMILIDE versus SOTALOL on programmed cardioversion in patients with atrial fibrillation. 2001-2003.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Professional Experience

• 1999-2000: Şırnak Military Hospital, Military Service
• 2001-2007: Süreyyapaşa Chest, Heart, and Vascular Diseases Hospital, Cardiovascular Surgery Clinic
  • Contributed to the establishment of the Cardiovascular Surgery Clinic
  • 2005: Awarded the title of Associate Professor in Cardiovascular Surgery
• 2007-2009: Kartal Koşuyolu High Specialization Training and Research Hospital
• 2009-2011: Kartal Koşuyolu High Specialization Training and Research Hospital, Cardiovascular Surgery Clinic, Assistant Chief
• 2011-2017: Kartal Koşuyolu High Specialization Training and Research Hospital, Cardiovascular Surgery Clinic, Instructor
• 2016-2017: Kartal Koşuyolu High Specialization Training and Research Hospital, Cardiovascular Surgery Clinic, Education Officer
• 2017-2024: Bezmialem Vakıf University, Faculty of Medicine, Professor
  • Head of Cardiovascular Surgery Department, Bezmialem Vakıf University, Faculty of Medicine
• Since July 2024: Medipol Acıbadem District l Hospital, Cardiovascular Surgeon

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.